With it comes an onslaught of blockbuster brand-name drugs whose market exclusivity runs out, thus clearing the way for significantly lower-price prescription drugs which represent newfound revenue and profit for retail pharmacies and billions in health care savings for their patients.

At the same time as this new wave of generics hits the market, other events are transpiring that could threaten generic dispensing and pharmacy revenues.